Claims

Veterans and clinicians rate the CIMI-M as feasible, acceptable, and clinically useful in a preliminary evaluation

Claim · All claims
Evidence · 1 study (2 entries) · design r3 · q2
Currency · newest study 2026 · not yet checked against its sources · not reviewed by a person · recheck by 2029: tool and model accuracy changes quickly

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? Veterans rated the CIMI-M favorably (M = 7.63 on a 10-point scale) and clinicians rated it very positively (M = 8.41). → de Goede 2026

Evidence

de Goede 2026

de Goede, M. L., Boelen, P. A., Litz, B. T., & ter Heide, F. J. J. (2026). Mapping moral injury: Development and feasibility of the Clinical Interview for Moral Injury—military version (CIMI-M). PLOS One. https://doi.org/10.1371/journal.pone.0359553

q2 · i? · design · r3

Descriptive statistics from a feasibility study at two Dutch tertiary trauma centers with eight veterans who completed the Debriefing Instrument for Patients and a 10-point overall rating. The study reports "an average rating of M = 7.63 (SD = 1.16, range 5–9)"; no effect sizes or inferential tests are printed.

"Veterans rated the CIMI-M favorably, with an average rating of M = 7.63 (SD = 1.16, range 5–9)."

de Goede 2026 (2)

de Goede, M. L., Boelen, P. A., Litz, B. T., & ter Heide, F. J. J. (2026). Mapping moral injury: Development and feasibility of the Clinical Interview for Moral Injury—military version (CIMI-M). PLOS One. https://doi.org/10.1371/journal.pone.0359553

q2 · i? · design · r3

Descriptive statistics from the same feasibility study, from the Debriefing Instrument for Clinicians completed by seven clinicians, two of whom conducted the interview twice. The article prints "an average rating of M = 8.41 (SD = 0.38, range 7.50–8.50)" with no inferential statistics.

"Clinicians rated the CIMI-M very positively, with an average rating of M = 8.41 (SD = 0.38, range 7.50–8.50)."

Discussion

Page metadata
Field Value
type claim
id cimi-m-favorable-feasibility-ratings
title Veterans and clinicians rate the CIMI-M as feasible, acceptable, and clinically useful in a preliminary evaluation
description Veterans and clinicians rate the CIMI-M as feasible, acceptable, and clinically useful in a preliminary evaluation
status review
evidence_strength weak
newest_evidence 2026
recheck_by 2029
generated by process:wiki-ingest on 2026-10-02
trust unverified — no one has confirmed this page's content
sources 2 — de-goede-2026, de-goede-2026-2

Frontmatter is the page's machine-readable record — see the Schema & Guide.